Β  Β  Β  Β  Β  Β  Β  Β 
Β  Β  Β  Β 

πŸ’Š Medications in Malaysia are Continually Monitored to Ensure Their Safety πŸ”Ž

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive
 

Β 

Β 

πŸ’ŠΒ Medicines in Malaysia are continually monitored to ensure their safety.πŸ”Ž

Reports of potential side effects from patients and healthcare professionals form an essential part of #pharmacovigilance system.


βœ… These reports help regulatory agencies assess the safety of medicines after they have been placed on the market and throughout the product life cycle, improving #PatientSafety worldwide.

βœ… Learn how you can #ReportSideEffects πŸ‘‰ NPRA (πŸ‘‰ as a healthcare professional or πŸ‘‰ a consumer) through 🌐 www.npra.gov.my.

Β 

Β 

πŸ’ŠΒ Ubat-ubatan di Malaysia sentiasa dipantau secara berterusan untuk memastikan keselamatannya.Β πŸ”Ž

Laporan mengenai kesan sampingan yang diterima daripada pesakit dan anggota kesihatan membantu dalam pemantauan keselamatan ini.

Β 

βœ… Laporan ini membantu pihak NPRAΒ  bagi menilai keselamatan ubat setelah dipasarkan serta memastikan ubat terus selamat untuk digunakan oleh pengguna.

βœ… Ketahui bagaimana anda boleh melaporkan kesan sampingan yang terjadi kepada NPRA (πŸ‘‰ sebagai anggota kesihatan atau πŸ‘‰ sebagai pengguna) melalui 🌐 www.npra.gov.my

Β 


#MedSafetyWeek #ReportSideEffects #NPRA #laporkesansampingan #ConSERF

Β 

Β 

Β 

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

  • Phone: +603-7883 5400

Β 

Β 

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Site Last Modified

  • Last Modified: Friday 12 July 2024, 15:24:37.
Β© Copyright 2023 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Search

Main Menu English